Skip to content

Innovation funding: fund your roadmap without giving up equity

When budgets tighten, the first reflex is usually to limit the scope of development projects. That slows down exactly the work that would make the difference tomorrow. Public research funding applies precisely here. It turns development work from a pure cost block into a forecastable cash flow, without diluting your equity, and protects your technological lead.

3D Spark
2R
Folienwelt
qlero
mm lab
Deutsche Firmenkredit Partner
ENTIAC
selecta one
DC Smarter
ZWF
Unternehmensgruppe Albert Weil
fierythings

Why research funding protects your roadmap

Development costs time, people and capital. When capital gets tight, the cuts usually land on the exploratory projects with the greatest potential. Research funding creates room for exactly those: for development time, prototypes, tests and the detours that belong to any serious development work.

The effect is not only financial. Teams that know part of the development cost is covered plan differently: longer test series, more variants, fewer premature stops.

Innovation stops being a cost block you defend every budget round and becomes a forecastable, non-dilutive layer behind the roadmap you already have.

There is public funding available for exactly this kind of work, because research and development are what most European programmes are designed to support. The difficulty is practical. Programmes are hard to track, eligibility is easy to misjudge, and the applications take time that engineering teams do not have. So the funding that could protect the roadmap often goes unclaimed, and the roadmap gets shortened instead.

Much of this funding, in the form of R&D tax credits and grants, is also money you do not repay and do not give up equity for. For a company that is investing ahead of revenue, that makes it the cheapest way to keep building.

It saves equity and cash. R&D tax credits return cash against money you are already spending, and grants cover work you were going to do anyway. That is capital you do not have to raise, which for a younger company often means a longer runway and a cleaner cap table.

It lets you move faster. Funding identified early and planned across the roadmap means you can start the next piece of work sooner, rather than waiting for it to compete for internal budget.

The point is not to add administration to your teams. It is to fund the work you were always going to do.

Which instruments carry your research and development

Several instruments are often available at the same time for research and development. We build a funding strategy for your whole project portfolio and check which approach fits which project. The overview below separates instruments by scope.

01

European programmes, available in every market

Horizon Europe: collaborative research and development, usually in multi-country consortia.

EIC Accelerator: market-facing innovation with breakthrough potential, for single companies.

EUREKA Eurostars: international R&D projects by smaller companies. Note that Eurostars is not part of Horizon Europe but draws on its own source.

These programmes offer considerably more volume but ask for more in return: international consortia, longer lead times and substantially more work on the application. Success rates at the top European programmes are markedly lower than for national instruments. A European application should therefore never be the only pillar of your development financing, but the addition to a solid base.

02

German market only

Forschungszulage: a tax-based instrument open to all companies liable to tax in Germany, retroactive for up to four years and without application deadlines. The plannable base of any funding strategy.

ZIM: grant programme for development work by small and medium-sized enterprises, alone or in collaboration.

kmu-innovativ and IGP: thematically targeted calls with their own deadlines.

Since 7 July 2026, ZIM has not been accepting new applications, with the exception of open international calls. Resumption is planned for early 2027.

03

Dutch market only

WBSO: the base instrument, reducing payroll tax for staff working on research and development. Works monthly and also without profit.

MIT R&D: regional tender for collaborative R&D between at least two SMEs, assessed by ranking rather than first come first served.

Innovatiebox, MIT feasibility studies and DHI: further national instruments covering profit from innovation, early feasibility work and international demonstration.

What the funding means for the other roles

A funded roadmap is a more resilient one. Public funding lets you keep investing in the technology that sets your position, without a new equity round and without cutting the work when the market turns.

It is a way to finance growth on steadier terms.

Handled well, research and development stops being a pure cost line and starts returning capital, quarter after quarter. An audit-ready structure is what turns a later review into a confirmation rather than a threat.

A claim is only useful if it survives scrutiny, and the documentation discipline is what separates dependable non-dilutive capital from a claim that will not hold up.

How we accelerate your development

Funding research and development well depends on understanding the research and development. The judgement that matters, which projects qualify and how to describe them so an evaluator agrees, is made by people who know both the technology and the programmes, and many of our specialists come from technical backgrounds and can hold that conversation at the right level. Technology runs in the background to widen the search, support the analysis and take over the repetitive administrative work, which leaves our specialists more time for your team and for the technical detail of each case. It does not decide what is eligible or how a case is made. The human factor is the one that carries the result.

01

Review the roadmap.

We go through your development work and separate what qualifies from routine activity.

02

Identify the right funding.

Not every programme fits every project. We find the funding that matches your development pipeline and your objectives.

03

Write a convincing application.

We write against the actual evaluation criteria and present the technical uncertainty so that it is traceable.

04

Protect what is awarded.

We keep time records, drawdowns and evidence audit-proof throughout the funded period.

This is the whole point of how we work. Your team keeps doing the development, and we make sure it gets funded to the maximum that is realistically possible: least effort from your side, best outcome, lowest compliance risk.

The people behind your application

LinkedIn

Dr. Marco Nesarajah

Senior Manager

Dr. Christian Spengler

Senior Consultant

Dr. Christoph Sandhöfer

Consultant

LinkedIn

Dr. Felix Felgner

Senior Consultant

LinkedIn

Dr. Hans Georg Breunig

Senior Consultant

LinkedIn

Dr. Navina Dahmke

Senior Consultant

What sets us apart

500Million

funding realized in 2025

Start your Funding Scan

What makes the difference

Your competitors are already using public funding to keep their development moving, and it is funding you have earned just as much. The difference over time comes down to who secures it early and who lets good projects get cut for the wrong reason.

When funding is planned into the roadmap from the start, rather than chased once a year, you keep building through the cycles that would otherwise slow you down.

FAQs about funding advisory

View all FAQs

Public money for research and development that you generally do not repay. In both markets a tax-based instrument forms the base, complemented by national grant programmes and European instruments.

More than most teams assume. Public funding is generally aimed at work that resolves genuine technical uncertainty, which includes developing new products, processes or software, and improving existing ones, not only research in a laboratory. The judgement is case by case, and it is exactly the kind of call our specialists make together with your technical team.

Most research funding does not have to be repaid. Tax-based instruments such as WBSO in the Netherlands and Forschungszulage in Germany return value against money you have already spent, and grants fund agreed work rather than lending against it. You also do not give up equity for it, which is why it is often the cheapest capital available for development work.

Yes. The tax-based instruments are designed to reach companies whether or not they are making a profit, because they work through payroll and R&D cost rather than through the tax owed on profit. For a pre-revenue company that usually means real value against the salaries of the people doing the work.

That depends on the instrument. The German Forschungszulage is retroactive for up to four years, so a first claim can reach back over costs you have already carried. The Dutch WBSO works the other way and has to be applied for before the work starts. Knowing which is which, and applying in time for the ones that need it, is part of what we manage.

It depends on the instruments you qualify for and the rules that apply when they are combined. Rather than promise a headline percentage, we map the eligible schemes, model what they return across your portfolio, and give you a realistic figure before you commit any of your team’s time.

Frequently yes. What decides it is the cost delimitation: the same costs may not be funded twice. Within one project, different cost elements can run through different instruments.

We therefore build a funding roadmap with you: completed, running and planned projects are each matched to the right instrument, and within each project the costs are separated cleanly.

It varies by instrument, and the timing is worth planning for. The Dutch WBSO is applied for in advance and takes effect monthly through the payroll. The German Forschungszulage works through the tax assessment. Competitive grants follow fixed call windows that can run several months from application to decision. We plan around those timelines so funding lines up with your roadmap rather than dictating it.

We write the application and support the annexes. What we need from you is the technical substance, and that can come through different routes: conversations, appointments or existing project documentation. We agree with you what works best.

No. What is funded is the attempt at development, not the success. What matters is that the work actually took place and is documented.

That is what the documentation discipline is for. We set up an audit-ready structure from the start, so the evidence behind every claim is in order before any authority asks for it. A later review then becomes a confirmation rather than a threat.

Many customers come to us alongside their existing advisers. The difference is specialisation and coverage: we track thousands of programmes across Europe, we understand the technical work well enough to describe it the way an evaluator needs, and we manage the full lifecycle from eligibility through audit. That combination tends to find and protect more than a generalist can.